Status:

COMPLETED

Validation Study of Covariates Model (VaSCoM) for Propofol

Lead Sponsor:

Golden Jubilee National Hospital

Conditions:

Target Controlled Infusion of Propofol

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Anaesthesia for surgical procedures can be provided using a continuous infusion of intravenous drug. The most commonly used drug for this technique is propofol. Infusion devices programmed with pharma...

Eligibility Criteria

Inclusion

  • Aged over 18 years
  • ASA I/II
  • Elective non-cardiac surgery expected to last longer than 30 minutes

Exclusion

  • Patient refusal or unable to consent
  • Premedication, sedative or anaesthetic in the previous 12 hours
  • Pre-operative GCS less than 15
  • ASA III/IV
  • Allergy to constituents of propofol
  • Excess alcohol intake
  • Drug abuse
  • Mental retardation
  • Difficult airway
  • BMI over 35

Key Trial Info

Start Date :

January 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2013

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT01492712

Start Date

January 1 2011

End Date

February 1 2013

Last Update

August 14 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Golden Jubilee National Hospital

Clydebank, United Kingdom, G81 4HX

Validation Study of Covariates Model (VaSCoM) for Propofol | DecenTrialz